Print this page
Tuesday, 17 January 2017 13:13

Recall Of Apo-Cabergoline 500mcg By Singapore’s Health Authority (HSA).

The attention of the Agency has been drawn to the recent recall of one batch of Apo-Cabergoline (500MCG) by the Singapore Health Authority due to the desiccant present in the bottle cap of the drug which may not protect the product from moisture through the shelf-life thereby resulting to the reduction/degrading of the active ingredient overtime on long-term storage.

Apo-Cabergoline is a drug used to treat different types of medical problems that occur when too much of the hormone prolactin is produced. It can be used to treat certain menstrual problems, fertility problems in men and women, pituitary prolactinomas (Tumours of the pituitary gland)

Details of the product:

Product name: Apo-Cabergoline 500MCG

Batch number: MK0903

Expiry date: 02/2017

Visual colour: White coloured, capsule shaped flat scored tablets.

Dosage form: Tablet

Park type: Bottle

Healthcare providers and pharmacists in possession of the above drug should take note and inform patients, also return all the unused products to the nearest NAFDAC office nationwide.

NAFDAC encourages healthcare professionals and patients to report adverse events or side effects related to the use of these products to NAFDAC PRASCOR (20543-Toll free from all networks) or via This email address is being protected from spambots. You need JavaScript enabled to view it.


NAFDAC...... Safeguarding the health of the nation!!!

Read 2468 times Last modified on Tuesday, 17 January 2017 13:21